A substantial body of work indicates that tumours arising in patients with germline BRCA1 mutations are morphologically and genetically distinct from those arising in carriers of BRCA2 mutations and from tumours in patients lacking mutations. The gene discussed is BRCA1; the disease is neoplasm.